Calando's double-whammy: Targets delivery of nanoparticles, demonstrates RNAi in humans
March 23, 2010 | Analyst Insight
The world awoke on Sunday to breathless headlines that nanotech is beating back cancer, with BusinessWeek declaring "Gene-Targeted Cancer Fix Could Be a Breakthrough" and Reuters explaining that "Nanotech robots...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.